Furthermore, IPA further revealed that the dysregulated genes in myxoma-derived CSCs are components of several canonical pathways (Figure 4C) such as HGF and IGF-1 signalling, telomerase signalling, stem cell pluripotency, and stem cell signalling among others (Figure 4C). Here, IGF1 is linked to myxoma.